Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             147 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgement of reviewers 2013 2014
6 p. 588-589
artikel
2 Acknowledgement of reviewers 2014 2015
6 p. 924-925
artikel
3 Acknowledgement of reviewers 2015 2016
6 p. 657-658
artikel
4 Acknowledgment of Reviewers 2016 and 2017 2018
6 p. 664-665
artikel
5 ACRODAT® and AcroVoice: an insight into a holistic approach to the management of acromegaly Lundie, Mark
2019
6 p. 647-648
artikel
6 Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing’s disease Araki, Takako

6 p. 859-866
artikel
7 Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche? Hölsken, Annett
2013
6 p. 546-556
artikel
8 A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry Salvatori, Roberto
2017
6 p. 605-618
artikel
9 Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients Ceccato, Filippo

6 p. 914-921
artikel
10 An Infundibular Unidentified Object (IUO): a new pituitary stalk marker? Bonneville, J.-F.

6 p. 964-969
artikel
11 A novel mutation in SOX3 polyalanine tract: a case of kabuki syndrome with combined pituitary hormone deficiency harboring double mutations in MLL2 and SOX3 Takagi, Masaki
2013
6 p. 569-574
artikel
12 Assessment of forearm muscles with ultrasound shear wave elastography in patients with acromegaly Coskun, Meric

6 p. 716-724
artikel
13 A tale of pituitary adenomas: to NET or not to NET Ho, Ken K. Y.
2019
6 p. 569-573
artikel
14 AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus Turkkahraman, Doga
2015
6 p. 898-904
artikel
15 Biochemical and quality of life responses to octreotide-LAR in acromegaly Mangupli, Ruth
2013
6 p. 495-499
artikel
16 BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series La Corte, Emanuele
2018
6 p. 571-583
artikel
17 Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults? Diri, Halit
2015
6 p. 884-892
artikel
18 Changing the name of diabetes insipidus Arima, Hiroshi

6 p. 777-779
artikel
19 Characterization of sporadic somatotropinomas with high GIP receptor expression Faria, Olivia

6 p. 903-910
artikel
20 Childhood acromegaly due to X-linked acrogigantism: long term follow-up Gordon, Rebecca J.
2016
6 p. 560-564
artikel
21 Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review Al-Aridi, Ribal
2013
6 p. 575-587
artikel
22 Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis Vuong, Huy Gia

6 p. 653-659
artikel
23 Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases Chen, Meiping

6 p. 675-685
artikel
24 Clinical efficacy of optical coherence tomography in sellar mass lesions: a meta-analysis Chou, Yuyu

6 p. 733-744
artikel
25 Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients Thakur, Jai Deep

6 p. 930-942
artikel
26 Copeptin response to hypoglycemic stress is linked to prolactin activation in children Drummond, Juliana B.

6 p. 681-690
artikel
27 Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing’s disease Siegel, Sonja
2016
6 p. 590-600
artikel
28 Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery? van Trigt, Victoria R.

6 p. 725-728
artikel
29 Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement Casanueva, Felipe F.
2018
6 p. 663
artikel
30 Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results Labadzhyan, Artak

6 p. 954
artikel
31 Correction to: Retrospective multicentric study of pituitary incidentalomas Fainstein-Day, Patricia
2019
6 p. 649
artikel
32 Cost-effectiveness of acromegaly treatments: a systematic review Leonart, Letícia P.
2018
6 p. 642-652
artikel
33 Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas Caulley, Lisa

6 p. 868-881
artikel
34 Cushing’s disease and co-existing phaeochromocytoma Johnston, Philip C.
2015
6 p. 654-656
artikel
35 Cushing’s syndrome is associated with sleep alterations detected by wrist actigraphy D’Angelo, Valentina
2015
6 p. 893-897
artikel
36 Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly Varlamov, Elena V.

6 p. 672-680
artikel
37 Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy Ajmal, Adnan
2018
6 p. 624-630
artikel
38 Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon Bonneville, Jean-François

6 p. 861-867
artikel
39 Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis Ribeiro de Moura, Cláudia

6 p. 780-794
artikel
40 Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours Lenders, N. F.

6 p. 997-1003
artikel
41 Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly Lely, Aart J. van der
2017
6 p. 692-701
artikel
42 Development of a novel patient-reported measure for acromegaly: the Acro-TSQ Fleseriu, Maria
2019
6 p. 581-593
artikel
43 Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score Castle-Kirszbaum, Mendel

6 p. 867-877
artikel
44 Double adenomas of the pituitary reveal distinct lineage markers, copy number alterations, and epigenetic profiles Hagel, Christian

6 p. 904-913
artikel
45 Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature Ogando-Rivas, Elizabeth
2017
6 p. 702-708
artikel
46 Double pituitary adenomas in a large surgical series Zieliński, Grzegorz
2019
6 p. 620-632
artikel
47 Downregulation of Insulin-like growth factor binding protein 6 is associated with ACTH-secreting pituitary adenoma growth Yang, Yakun
2013
6 p. 505-513
artikel
48 Ectopic hyperprolactinaemia due to a malignant uterine tumor resembling ovarian sex cord tumors (UTROCST) Dimitriadis, Georgios K.

6 p. 641-647
artikel
49 Ectopic pituitary adenomas: clinical features, diagnostic challenges and management Zhu, Jianyu

6 p. 648-664
artikel
50 Effectiveness of medical treatment for Cushing’s syndrome: a systematic review and meta-analysis Broersen, Leonie H. A.
2018
6 p. 631-641
artikel
51 Endoscopic endonasal marsupialization of rathke cleft cysts: clinical outcomes and risk factors analysis of visual impairment, pituitary dysfunction, and CSF leak Alsavaf, Mohammad Bilal

6 p. 696-707
artikel
52 Evidence of dysexecutive syndrome in patients with acromegaly Shan, Shaobo
2017
6 p. 661-667
artikel
53 Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas Verma, Jonathan
2013
6 p. 539-545
artikel
54 Frailty does not preclude surgical success after endoscopic transsphenoidal surgery for pituitary adenomas Castle-Kirszbaum, Mendel

6 p. 922-929
artikel
55 Gamma Knife radiosurgery for medically and surgically refractory prolactinomas: long-term results Cohen-Inbar, Or
2015
6 p. 820-830
artikel
56 Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation Gologorsky, Rachel

6 p. 842-853
artikel
57 Genetic spectrum and predictors of mutations in four known genes in Asian Indian patients with growth hormone deficiency and orthotopic posterior pituitary: an emphasis on regional genetic diversity Kale, Shantanu

6 p. 701-715
artikel
58 Giant prolactinoma in children and adolescents: a single-center experience and systematic review Kumar, Sandeep

6 p. 819-830
artikel
59 Granular cell tumors of the sellar region: what should be done after subtotal resection? A systematic review Rubino, Franco

6 p. 721-732
artikel
60 Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans Young, Jonathan A.

6 p. 660-674
artikel
61 High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors Wang, Shirui

6 p. 938-947
artikel
62 Historical and future trends in emergency pituitary referrals: a machine learning analysis Pandit, A. S.

6 p. 927-937
artikel
63 Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study Iraqi, H. Masri

6 p. 982-987
artikel
64 IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition Reid, Tirissa J.
2015
6 p. 808-819
artikel
65 Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis Efstathiadou, Z. A.
2015
6 p. 861-867
artikel
66 Impact of histopathological classification of non-functioning adenomas on long term outcomes: comparison of the 2004 and 2017 WHO classifications Chatrath, Ajay

6 p. 988-996
artikel
67 Impact of selective pituitary gland incision or resection on hormonal function after adenoma or cyst resection Barkhoudarian, Garni
2015
6 p. 868-875
artikel
68 Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience Chiloiro, Sabrina

6 p. 831-841
artikel
69 Impact of treatment satisfaction on quality of life of patients with acromegaly Kepicoglu, Hasan
2013
6 p. 557-563
artikel
70 Incidence and risk factors of subdural hematoma after intraoperative cerebrospinal fluid leakage during the transsphenoidal approach Takeuchi, Kazuhito
2016
6 p. 565-572
artikel
71 Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry Schöfl, Christof
2017
6 p. 635-642
artikel
72 Incremental healthcare resource utilization and costs in US patients with Cushing’s disease compared with diabetes mellitus and population controls Broder, Michael S.
2015
6 p. 796-802
artikel
73 Influence of growth hormone therapy on germinoma survivors Kinoshita, Yasuyuki

6 p. 854-860
artikel
74 Infundibulo-tuberal syndrome: the origins of clinical neuroendocrinology in France Castro-Dufourny, Inés
2015
6 p. 838-843
artikel
75 In Memoriam: Lawrence A. Frohman, M.D. January 26, 1935–March 4, 2018 Reichlin, Seymour
2018
6 p. 559-560
artikel
76 Intrasellar symptomatic salivary gland: case series and literature review Liu, Zhiyong
2019
6 p. 640-646
artikel
77 Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS) Pivonello, Rosario

6 p. 911-926
artikel
78 Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2) Fleseriu, Maria

6 p. 959-970
artikel
79 Long-term hepatic and cardiac health in patients diagnosed with Sheehan’s syndrome Das, Liza

6 p. 971-981
artikel
80 Long-term outcomes of children treated for Cushing’s disease: a single center experience Yordanova, Galina
2016
6 p. 612-624
artikel
81 Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naïve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment Warszawski, Leila
2016
6 p. 582-589
artikel
82 Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study Samson, Susan L.

6 p. 887-903
artikel
83 Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review Česák, Tomáš
2018
6 p. 561-570
artikel
84 Metastases to the pituitary gland: insights from the German pituitary tumor registry Haberbosch, Linus

6 p. 708-715
artikel
85 MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas Micko, Alexander S. G.
2017
6 p. 643-653
artikel
86 MGMT immunohistochemistry in pituitary tumors: controversies with clinical implications Kontogeorgos, George
2019
6 p. 614-619
artikel
87 “Micromegaly”: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era Butz, Laura B.
2016
6 p. 547-551
artikel
88 Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas Lecumberri, Beatriz
2015
6 p. 782-795
artikel
89 Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results Labadzhyan, Artak

6 p. 943-953
artikel
90 Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing’s disease Sherry, Alexander D.
2019
6 p. 607-613
artikel
91 Paradoxical and atypical responses to pasireotide in aggressive ACTH-secreting pituitary tumors Greenman, Yona
2016
6 p. 605-611
artikel
92 Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial MacKenzie Feder, Jessica
2013
6 p. 519-529
artikel
93 Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation Maclean, Jillian
2013
6 p. 530-538
artikel
94 Pituitary apoplexy and panhypopituitarism following acute leptospirosis Gohil, Jaypalsinh

6 p. 854-858
artikel
95 Pituitary apoplexy and rivaroxaban Ly, S.
2017
6 p. 709-710
artikel
96 Pituitary apoplexy associated with acute COVID-19 infection and pregnancy Chan, Julie L.

6 p. 716-720
artikel
97 Pituitary carcinoma with fourth ventricle metastasis: treatment by excision and Gamma-knife radiosurgery Park, Ki-Su
2013
6 p. 514-518
artikel
98 Pituitary incidentalomas: analysis of a neuroradiological cohort Esteves, César
2015
6 p. 777-781
artikel
99 Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection Marcus, Hani J.

6 p. 839-853
artikel
100 Pituitary tumors in MEN1: do not be misled by borderline elevated prolactin levels Livshits, Alina
2016
6 p. 601-604
artikel
101 Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis Parolin, Matteo
2018
6 p. 653-662
artikel
102 Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma Rudman, Yaron

6 p. 882-890
artikel
103 Prediction of postoperative diabetes insipidus using morphological hyperintensity patterns in the pituitary stalk on magnetic resonance imaging after transsphenoidal surgery for sellar tumors Hayashi, Yasuhiko
2016
6 p. 552-559
artikel
104 Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy Nadezhdina, Elena Y.
2019
6 p. 574-580
artikel
105 Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort Sievers, Caroline
2015
6 p. 916-923
artikel
106 Predictors of hypopituitarism due to vasculotoxic snake bite with acute kidney injury Bhat, Sowrabha
2019
6 p. 594-600
artikel
107 Pregnancy-associated Cushing’s disease? An exploratory retrospective study Palejwala, Sheri K.
2018
6 p. 584-592
artikel
108 Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly Albarel, F.
2018
6 p. 615-623
artikel
109 Prevalence of AIP mutations in a series of Turkish acromegalic patients: are synonymous AIP mutations relevant? Karaca, Z.
2015
6 p. 831-837
artikel
110 Primary sellar melanocytoma Claus, M.

6 p. 970-977
artikel
111 Problem-solving therapy can reduce psychological distress in patients with Cushing’s disease: a randomized controlled trial Sulu, Cem

6 p. 891-902
artikel
112 Prolactin levels in manganese-exposed male welders Tutkun, Engin
2013
6 p. 564-568
artikel
113 Radiomics model predicts granulation pattern in growth hormone-secreting pituitary adenomas Park, Yae Won

6 p. 691-700
artikel
114 Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review Layard Horsfall, Hugo

6 p. 645-652
artikel
115 Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects Bellastella, Giuseppe
2016
6 p. 625-642
artikel
116 Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects Bellastella, Giuseppe

6 p. 625-642
artikel
117 Secondary pituitary hormonal dysfunction patterns: tumor size and subtype matter Almistehi, Wael M.

6 p. 622-629
artikel
118 Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI Berkmann, Sven

6 p. 878-886
artikel
119 Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus Jang, Han Na

6 p. 1004-1014
artikel
120 Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients: comparison with an age- and sex-matched nationwide control group Khang, Ah Reum
2016
6 p. 573-581
artikel
121 Shall we be less aggressive in pituitary surgery in the elderly? Martinez-Perez, Rafael

6 p. 745-747
artikel
122 Single center study of 53 consecutive patients with pituitary stalk lesions Doknic, Mirjana
2018
6 p. 605-614
artikel
123 Sphenoid sinus microbiota in pituitary apoplexy: a preliminary study Humphreys, Gavin J.
2017
6 p. 619-623
artikel
124 Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results Carvalho, Pedro
2015
6 p. 844-860
artikel
125 Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas Park, Ji Yong

6 p. 955-963
artikel
126 Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly Fahlbusch, Rudolf
2017
6 p. 668-675
artikel
127 Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis Yagnik, Karan J.

6 p. 978-988
artikel
128 Surgical resection of granular cell tumor of the sellar region: three indications Ahmed, Abdul-Kareem
2019
6 p. 633-639
artikel
129 Tamoxifen as a therapeutic agent in acromegaly Balili, Irida
2013
6 p. 500-504
artikel
130 Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells Marucci, Gianluca
2015
6 p. 905-911
artikel
131 The acromegalic spine: fractures, deformities and spinopelvic balance Azevedo Oliveira, Bruno de
2019
6 p. 601-606
artikel
132 The changing sella: internal carotid artery shift during transsphenoidal pituitary surgery Serra, Carlo
2017
6 p. 654-660
artikel
133 The 5-factor modified frailty index predicts health burden following surgery for pituitary adenomas Khalafallah, Adham M.

6 p. 630-640
artikel
134 The impact of facility type and volume on treatment and overall survival in craniopharyngioma Bitner, Benjamin F.

6 p. 686-695
artikel
135 The importance of specialized sleep investigations in children with a suprasellar tumor van Schaik, J.

6 p. 613-621
artikel
136 The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013 Hoskuldsdottir, Gudrun Thuridur
2015
6 p. 803-807
artikel
137 The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study Giritharan, Sumithra
2017
6 p. 624-634
artikel
138 The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL Yoshida, Kenichi
2015
6 p. 876-883
artikel
139 The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases Wei, Zhishuo

6 p. 948-958
artikel
140 Thyroid autoimmune disorders in patients with acromegaly Manavela, M.
2015
6 p. 912-915
artikel
141 Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples Fleseriu, Maria

6 p. 795-809
artikel
142 Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis Botelho, Mayra Souza

6 p. 810-818
artikel
143 Treatment of sellar metastases with gamma knife radiosurgery in patients with advanced cancer Benjamin, Carolina

6 p. 665-671
artikel
144 Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies Fleseriu, Maria
2016
6 p. 643-653
artikel
145 Vasculogenic hyperprolactinemia: severe prolactin excess in association with internal carotid artery aneurysms De Sousa, Sunita M. C.
2017
6 p. 676-682
artikel
146 Walter E. Dandy: his contributions to pituitary surgery in the context of the overall Johns Hopkins Hospital experience Corsello, Andrea
2017
6 p. 683-691
artikel
147 Work disability and its determinants in patients with pituitary tumor-related disease Lobatto, Daniel J.
2018
6 p. 593-604
artikel
                             147 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland